116 related articles for article (PubMed ID: 37581517)
1. C-C Motif Chemokine Ligand 5 (CCL5): A Potential Biomarker and Immunotherapy Target for Osteosarcoma.
Zheng H; Wang Y; Li F
Curr Cancer Drug Targets; 2024; 24(3):308-318. PubMed ID: 37581517
[TBL] [Abstract][Full Text] [Related]
2. Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Rheumatoid Arthritis by Bioinformatics Analysis.
Zhou S; Lu H; Xiong M
Front Immunol; 2021; 12():726747. PubMed ID: 34484236
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of novel biomarkers associated with immune infiltration for the diagnosis of osteosarcoma based on machine learning.
Ji Y; Lin Z; Li G; Tian X; Wu Y; Wan J; Liu T; Xu M
Front Genet; 2023; 14():1136783. PubMed ID: 37732314
[No Abstract] [Full Text] [Related]
4. Machine learning-based screening of the diagnostic genes and their relationship with immune-cell infiltration in patients with lung adenocarcinoma.
Wang S; Wang Q; Fan B; Gong J; Sun L; Hu B; Wang D
J Thorac Dis; 2022 Mar; 14(3):699-711. PubMed ID: 35399247
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
Front Immunol; 2022; 13():997765. PubMed ID: 36275664
[TBL] [Abstract][Full Text] [Related]
6. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
7. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
[TBL] [Abstract][Full Text] [Related]
8. Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients.
Zhang Z; Liu C; Liang T; Yu C; Qin Z; Zhou X; Xue J; Zeng H; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
Medicine (Baltimore); 2020 Nov; 99(46):e23251. PubMed ID: 33181717
[TBL] [Abstract][Full Text] [Related]
9. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
Tan S; Chao R
Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
[TBL] [Abstract][Full Text] [Related]
10. Six potential biomarkers in septic shock: a deep bioinformatics and prospective observational study.
Kong C; Zhu Y; Xie X; Wu J; Qian M
Front Immunol; 2023; 14():1184700. PubMed ID: 37359526
[TBL] [Abstract][Full Text] [Related]
11. Identifying immune cell infiltration and effective diagnostic biomarkers in Crohn's disease by bioinformatics analysis.
Huang R; Wang W; Chen Z; Chai J; Qi Q; Zheng H; Chen B; Wu H; Liu H
Front Immunol; 2023; 14():1162473. PubMed ID: 37622114
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel biomarkers and immune infiltration characteristics of ischemic stroke based on comprehensive bioinformatic analysis and machine learning.
Hu S; Cai J; Chen S; Wang Y; Ren L
Biochem Biophys Rep; 2024 Mar; 37():101595. PubMed ID: 38371524
[TBL] [Abstract][Full Text] [Related]
13. Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis.
Wang L; Yang Z; Yu H; Lin W; Wu R; Yang H; Yang K
Front Immunol; 2022; 13():839197. PubMed ID: 36532018
[TBL] [Abstract][Full Text] [Related]
14. Association of the
Chen S; Ke Y; Chen W; Wu S; Zhuang X; Lin Q; Shi Q; Wu Z
Front Mol Biosci; 2023; 10():1209144. PubMed ID: 37635936
[No Abstract] [Full Text] [Related]
15. Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.
Gong Y; Wei ZR
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1522. PubMed ID: 34383385
[TBL] [Abstract][Full Text] [Related]
16. Identification of TYR, TYRP1, DCT and LARP7 as related biomarkers and immune infiltration characteristics of vitiligo via comprehensive strategies.
Zhang J; Yu R; Guo X; Zou Y; Chen S; Zhou K; Chen Y; Li Y; Gao S; Wu Y
Bioengineered; 2021 Dec; 12(1):2214-2227. PubMed ID: 34107850
[TBL] [Abstract][Full Text] [Related]
17. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.
He B; Quan LP; Cai CY; Yu DY; Yan W; Wei QJ; Zhang Z; Huang XN; Liu L
Front Cardiovasc Med; 2022; 9():973279. PubMed ID: 36148059
[TBL] [Abstract][Full Text] [Related]
19. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
20. [Screen of key characteristic genes of nasopharyngeal carcinoma (NPC) base on machine learning and analysis of their correlation with immune cells].
Zhang H; Ma J; An S; Xu L; Lu J; Jiang C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Number; 39(11):988-995. PubMed ID: 37980550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
